HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Christos Alexiou David Beggs Ruchan Akar Fayek D. Salama John P. Duffy Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexiou, C. Articles by Morgan, W. E. Search for Related Content PubMed PubMed Citation Articles by Alexiou, C. Articles by Morgan, W. E. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2002;21:319-325
© 2002 Elsevier Science NL

Do women live longer following lung resection for carcinoma?

Department of Cardiothoracic Surgery, City Hospital, Nottingham, NG5 1PB, UK

Received 19 September 2001; received in revised form 12 November 2001; accepted 19 November 2001.

* Corresponding author. Tel.: +44-116-2871471
e-mail: christosalexiou{at}hotmail.com

Objective: To determine whether patient gender affects the outlook following lung resection for non-small cell lung cancer (NSCLC). Patients and methods: Prospectively collected data on 833 patients undergoing lung resection for NSCLC between 1990 and 2000 in a single unit were analysed. Results: 581 patients were male (mean age 64.7±7 years) and 252 were female (mean age 62.6±7.8 years) (P=0.006). Male patients were more likely to have a history of ischaemic heart disease (P=0.03), to have poorer preoperative spirometry as demonstrated by their % predicted FEV1 (P=0.02) and to need pneumonectomy (P=0.0001) than their female counterparts. Squamous cell carcinoma was the predominant histological cell type in men and adenocarcinoma in women (P<0.0001). There was a trend towards a lower pathological stage among women, but this was not significant. Operative mortality for men was 4.6 and 1.2% for women (P=0.01). Overall 5-year survival for men was 34.2±2.65% and 47.5±4.2% for women (P=0.001) and, for the hospital survivors, was 36.5±2.7% and 48.1±4.2%, respectively (P=0.01). On univariate analysis, older age, the need for pneumonectomy and higher pathological stage were significant adverse factors whereas squamous cell type and female gender were significant favourable factors for survival (P<0.05). On Cox proportional hazards model (with and without hospital deaths), pathological stage (P<0.0001), female gender (P=0.0006) and squamous cell type (P=0.001) were independent predictors of survival. The survival was significantly better for women having squamous cell (P=0.01) or non-squamous cell cancers (adenocarcinoma and other) (P=0.002). Regarding the stage, women had a significant survival advantage at pathological stage I (P=0.01) and a relatively better survival at stage II and stage III disease (P=0.3). Conclusions: This study suggests that female gender exerts a significant positive effect on survival following lung resection for NSCLC. This effect is pronounced at early disease stage and persists after adjusting for important differences in the clinical, histo-pathological features and extent of pulmonary resection between male and female patients.

Key Words: Lung cancer • Gender • Survival

This article has been cited by other articles:

				C. Rodriguez, H. Spencer Feigelson, A. Deka, A. V. Patel, E. J. Jacobs, M. J. Thun, and E. E. Calle Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 655 - 660. [Abstract] [Full Text] [PDF]

				J. P. Wisnivesky and E. A. Halm Sex Differences in Lung Cancer Survival: Do Tumors Behave Differently in Elderly Women? J. Clin. Oncol., May 1, 2007; 25(13): 1705 - 1712. [Abstract] [Full Text] [PDF]

				A. Shaw Genetics of postoperative complications following thoracic surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345. [Abstract] [PDF]

				R. J. Cerfolio, A. S. Bryant, E. Scott, M. Sharma, F. Robert, S. A. Spencer, and R. I. Garver Women With Pathologic Stage I, II, and III Non-small Cell Lung Cancer Have Better Survival Than Men Chest, December 1, 2006; 130(6): 1796 - 1802. [Abstract] [Full Text] [PDF]

				International Early Lung Cancer Action Program Inv Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer JAMA, July 12, 2006; 296(2): 180 - 184. [Abstract] [Full Text] [PDF]

				A. I. Neugut and J. S. Jacobson Women and lung cancer: gender equality at a crossroad? JAMA, July 12, 2006; 296(2): 218 - 219. [Full Text] [PDF]

				L. E. Ferri, S. Law, K.-H. Wong, K.-F. Kwok, and J. Wong The Influence of Technical Complications on Postoperative Outcome and Survival After Esophagectomy Ann. Surg. Oncol., April 1, 2006; 13(4): 557 - 564. [Abstract] [Full Text] [PDF]

				C. Doddoli, B. D'Journo, F. Le Pimpec-Barthes, A. Dujon, C. Foucault, P. Thomas, and M. Riquet Lung Cancer Invading the Chest Wall: A Plea for En-Bloc Resection but the Need for New Treatment Strategies Ann. Thorac. Surg., December 1, 2005; 80(6): 2032 - 2040. [Abstract] [Full Text] [PDF]

				J. D. Patel Lung Cancer in Women J. Clin. Oncol., May 10, 2005; 23(14): 3212 - 3218. [Abstract] [Full Text] [PDF]

				J. B. Fu, T. Y. Kau, R. K. Severson, and G. P. Kalemkerian Lung Cancer in Women: Analysis of the National Surveillance, Epidemiology, and End Results Database Chest, March 1, 2005; 127(3): 768 - 777. [Abstract] [Full Text] [PDF]

				H. Rostad, A. Naalsund, T.-E. Strand, R. Jacobsen, O. Talleraas, and J. Norstein Results of pulmonary resection for lung cancer in Norway, patients older than 70 years Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 325 - 328. [Abstract] [Full Text] [PDF]

				A. L. Visbal, B. A. Williams, F. C. Nichols III, R. S. Marks, J. R. Jett, M.-C. Aubry, E. S. Edell, J. A. Wampfler, J. R. Molina, and P. Yang Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Ann. Thorac. Surg., July 1, 2004; 78(1): 209 - 215. [Abstract] [Full Text] [PDF]

				A. Iwasaki, T. Shirakusa, T. Shiraishi, and S. Yamamoto Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 158 - 164. [Abstract] [Full Text] [PDF]

				A. Campione, T. Ligabue, L. Luzzi, C. Ghiribelli, P. Paladini, L. Voltolini, M. Di Bisceglie, M. Lonzi, and G. Gotti Impact of Size, Histology, and Gender on Stage IA Non-Small Cell Lung Cancer Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 149 - 153. [Abstract] [Full Text] [PDF]

				J. D. Patel, P. B. Bach, and M. G. Kris Lung Cancer in US Women: A Contemporary Epidemic JAMA, April 14, 2004; 291(14): 1763 - 1768. [Abstract] [Full Text] [PDF]

				O. A. Khan, J. J. Fitzgerald, M. L. Field, I. Soomro, F. D. Beggs, W. E. Morgan, and J. P. Duffy Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung Ann. Thorac. Surg., April 1, 2004; 77(4): 1173 - 1178. [Abstract] [Full Text] [PDF]

				C. Alexiou, D. Beggs, P. Onyeaka, K. Kotidis, S. Ghosh, L. Beggs, D. N. Hopkinson, J. P. Duffy, W. E. Morgan, and G. Rocco Pneumonectomy for Stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Ann. Thorac. Surg., October 1, 2003; 76(4): 1023 - 1028. [Abstract] [Full Text] [PDF]